A newsletter by Reuters and Westlaw

By Sara Merken

What's going on today?

REUTERS/Jonathan Ernst

Within days of Donald Trump announcing his sweeping "Liberation Day" tariffs in April, Rick Woldenberg was looking for a law firm to help him sue the U.S. president.

"I'm not willing to allow politicians to destroy what we have built up over generations," said Woldenberg, CEO of educational toy company Learning Resources, a family business in the Chicago suburbs founded by his mother.

Woldenberg, along with attorneys at Akin Gump, will be at the U.S. Supreme Court on Wednesday to attempt to secure a historic victory. The nine justices will be hearing arguments in the case called Learning Resources v. Trump, along with two related cases in which plaintiffs also argue that the president's tariffs are unlawful.

One of the related cases was filed by Oregon and other Democratic-led states. The other was brought by the Liberty Justice Center, a libertarian nonprofit, on behalf of five small businesses, including a wine distributor called V.O.S. Selections and another educational toy company called MicroKits.

While the court typically takes months to issue rulings after hearing arguments, the Trump administration has asked it to act swiftly in this case. Read more about the tariffs litigation from Jan Wolfe. 

More coverage: 

Supreme Court won't stop Trump's tariffs. Deal with it, officials say

Trump says he will not attend Supreme Court's oral arguments on tariffs

REUTERS/Mike Blake/File Photo

Pfizer filed an antitrust lawsuit today accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech Metsera to stall, not close, the deal, a tactic it said is designed to suppress competition in obesity drugs. 

Pfizer agreed to pay up to $7.3 billion for Metsera in September. Last week, after Novo's top investor seized control of its board, the company launched a rival bid that Metsera – its seventh since January – said was superior to Pfizer's. It gave Pfizer until Tuesday to submit a higher offer.

Metsera said the latest lawsuit was an attempt by Pfizer to drive down its takeover price. Novo said its proposal was compelling and exceeds Pfizer’s. Read more.

Canada’s clampdown on international students has hit applicants from India particularly hard, government data shows … Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol maker struggles with weak sales, lawsuits and White House attacks linking its painkiller to autism … A powerful 6.3 magnitude earthquake struck near the northern Afghan city of Mazar-e Sharif … OpenAI has signed a seven-year, $38 billion deal to buy cloud services from Amazon. Plus, a look at how the U.S. is preparing a military staging ground near Venezuela.